FMP
Globe Life Inc.
GL
NYSE
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers whole life, term life, and other life insurance products; Medicare supplement and supplemental health insurance, such as critical illness and accident plans; and single-premium and flexible-premium deferred annuities. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was incorporated in 1979 and is headquartered in McKinney, Texas.
122.46 USD
0.775 (0.633%)
Operating Data
Year
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Revenue
4.74B
5.11B
5.21B
5.45B
5.78B
6.07B
6.38B
6.71B
7.05B
7.41B
Revenue %
-
7.91
2
4.46
6.07
5.11
5.11
5.11
5.11
Ebitda
-
1.02B
-
-
-
241.34M
253.67M
266.63M
280.26M
294.58M
Ebitda %
-
19.87
-
-
-
3.97
3.97
3.97
3.97
Ebit
-17M
995.88M
-21M
-
-
227.34M
238.96M
251.16M
264M
277.49M
Ebit %
-0.36
19.48
-0.4
-
-
3.74
3.74
3.74
3.74
Depreciation
17M
20M
21M
-
-
14M
14.72M
15.47M
16.26M
17.09M
Depreciation %
0.36
0.39
0.4
-
-
0.23
0.23
0.23
0.23
Balance Sheet
Year
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Total Cash
21.42B
21.47B
16.71B
103.16M
250.36M
3.72B
3.91B
4.11B
4.32B
4.54B
Total Cash %
452.02
419.85
320.43
1.89
4.33
61.25
61.25
61.25
61.25
Receivables
474.18M
487.44M
-
630.22M
691.91M
523.34M
550.08M
578.19M
607.73M
638.78M
Receivables %
10.01
9.53
-
11.57
11.97
8.62
8.62
8.62
8.62
Inventories
-998.2M
-999.82M
-18.1B
-
-
-1.71B
-1.8B
-1.89B
-1.98B
-2.08B
Inventories %
-21.07
-19.55
-347.17
-
-
-28.12
-28.12
-28.12
-28.12
Payable
399.51M
412.94M
509.36M
514.88M
532.83M
545.98M
573.87M
603.2M
634.02M
666.41M
Payable %
8.43
8.08
9.77
9.45
9.22
8.99
8.99
8.99
8.99
Cap Ex
-41.76M
-38.24M
-27.93M
-49.55M
-71.05M
-52.28M
-54.95M
-57.76M
-60.71M
-63.81M
Cap Ex %
-0.88
-0.75
-0.54
-0.91
-1.23
-0.86
-0.86
-0.86
-0.86
Weighted Average Cost Of Capital
Price
122.46
Beta
Diluted Shares Outstanding
84.75M
Costof Debt
30.6
Tax Rate
After Tax Cost Of Debt
24.69
Risk Free Rate
Market Risk Premium
Cost Of Equity
Total Debt
415.4M
Total Equity
10.38B
Total Capital
10.79B
Debt Weighting
3.85
Equity Weighting
96.15
Wacc
7.57
Build Up Free Cash Flow
Year
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Revenue
4.74B
5.11B
5.21B
5.45B
5.78B
6.07B
6.38B
6.71B
7.05B
7.41B
Ebitda
-
1.02B
-
-
-
241.34M
253.67M
266.63M
280.26M
294.58M
Ebit
-17M
995.88M
-21M
-
-
227.34M
238.96M
251.16M
264M
277.49M
Tax Rate
19.29
19.29
19.29
19.29
19.29
19.29
19.29
19.29
19.29
19.29
Ebiat
-13.87M
813.12M
-20.72M
-
-
192.76M
202.61M
212.96M
223.84M
235.28M
Depreciation
17M
20M
21M
-
-
14M
14.72M
15.47M
16.26M
17.09M
Receivables
474.18M
487.44M
-
630.22M
691.91M
523.34M
550.08M
578.19M
607.73M
638.78M
Inventories
-998.2M
-999.82M
-18.1B
-
-
-1.71B
-1.8B
-1.89B
-1.98B
-2.08B
Payable
399.51M
412.94M
509.36M
514.88M
532.83M
545.98M
573.87M
603.2M
634.02M
666.41M
Cap Ex
-41.76M
-38.24M
-27.93M
-49.55M
-71.05M
-52.28M
-54.95M
-57.76M
-60.71M
-63.81M
Ufcf
884.89M
796.67M
17.66B
-18.78B
-114.77M
2.04B
250.8M
263.62M
277.09M
291.24M
Wacc
7.57
7.57
7.57
7.57
7.57
Pv Ufcf
1.9B
216.74M
211.79M
206.94M
202.21M
Sum Pv Ufcf
2.74B
Terminal Value
Growth In Perpetuity Method
Long Term Growth Rate
Wacc
7.57
Free Cash Flow T1
297.07M
Terminal Value
5.34B
Present Terminal Value
3.71B
Intrinsic Value
Enterprise Value
6.44B
Net Debt
250.08M
Equity Value
6.19B
Diluted Shares Outstanding
84.75M
Equity Value Per Share
73.09
Projected DCF
73.09 -0.675%
